Carregant...

Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis Cells

The ability of Pseudomonas aeruginosa to form antibiotic-resistant biofilms is thought to account for the inability of current therapies to resolve bacterial infections in the lungs of patients with cystic fibrosis (CF). We recently described a system in which highly antibiotic-resistant P. aerugino...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Moreau-Marquis, Sophie, O'Toole, George A., Stanton, Bruce A.
Format: Artigo
Idioma:Inglês
Publicat: American Thoracic Society 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2742750/
https://ncbi.nlm.nih.gov/pubmed/19168700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2008-0299OC
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!